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Disruption of the Basal Body Protein POC1B
Results in Autosomal-Recessive Cone-Rod Dystrophy
Susanne Roosing,1,2,6,7,8 Ideke J.C. Lamers,1,2,8 Erik de Vrieze,1,3,8 L. Ingeborgh van den Born,4,8
Stanley Lambertus,5 Heleen H. Arts,1,2 POC1B Study Group, Theo A. Peters,3 Carel B. Hoyng,5
Hannie Kremer,1,2,3 Lisette Hetterschijt,1 Stef J.F. Letteboer,1,2 Erwin van Wijk,3,9 Ronald Roepman,1,2,9
Anneke I. den Hollander,1,2,5,9 and Frans P.M. Cremers1,2,9,*
Exome sequencing revealed a homozygous missense mutation (c.317C>G [p.Arg106Pro]) in POC1B, encoding POC1 centriolar protein
B, in three siblings with autosomal-recessive cone dystrophy or cone-rod dystrophy and compound-heterozygous POC1B mutations
(c.199_201del [p.Gln67del] and c.810þ1G>T) in an unrelated person with cone-rod dystrophy. Upon overexpression of POC1B in
human TERT-immortalized retinal pigment epithelium 1 cells, the encoded wild-type protein localized to the basal body of the primary
cilium, whereas this localizationwas lost for p.Arg106Pro and p.Gln67del variant forms of POC1B.Morpholino-oligonucleotide-induced
knockdown of poc1b translation in zebrafish resulted in a dose-dependent small-eye phenotype, impaired optokinetic responses, and
decreased length of photoreceptor outer segments. These ocular phenotypes could partially be rescued by wild-type human POC1B
mRNA, but not by c.199_201del and c.317C>G mutant human POC1B mRNAs. Yeast two-hybrid screening of a human retinal cDNA
library revealed FAM161A as a binary interaction partner of POC1B. This was confirmed in coimmunoprecipitation and colocalization
assays, which both showed loss of FAM161A interaction with p.Arg106Pro and p.Gln67del variant forms of POC1B. FAM161A was pre-
viously implicated in autosomal-recessive retinitis pigmentosa and shown to be located at the base of the photoreceptor connecting
cilium, where it interacts with several other ciliopathy-associated proteins. Altogether, this study demonstrates that POC1B mutations
result in a defect of the photoreceptor sensory cilium and thus affect cone and rod photoreceptors.Introduction
Inherited cone disorders are a heterogeneous group of
diseases that primarily affect cone photoreceptors and
have an estimated worldwide prevalence of 1:30,000–
1:40,000.1–3 They can be divided into progressive forms
of cone dystrophy (COD) and the more stationary disor-
ders, also named cone-dysfunction syndromes. The sta-
tionary subtypes, such as achromatopsia (ACHM), are
congenital, and childrenwith ACHMpresent with congen-
ital nystagmus, significantly reduced visual acuity, severe
photophobia, poor or absent color vision, and normal
fundi. Electroretinography (ERG) shows no or residual
cone responses and normal rod responses. COD, on the
other hand, starts in childhood or early adult life and
causes progressive deterioration of visual acuity and color
vision, as shown by reduced cone responses on ERG.4,5
The fundus examination in COD varies from normal to
either a bull’s eyemaculopathy or total atrophy of themac-
ular region.1 A considerable amount of individuals with
COD also develop rod dysfunction, leading to a cone-rod
dystrophy (CRD) with panretinal degeneration. In CRD,
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The Amerthe loss of cone function. So, apart from the loss of central
vision, individuals with CRD also experience night blind-
ness and loss of peripheral vision, leading to legal blind-
ness at an earlier age.1,6
Molecular genetic studies have identified five genes
mutated in individuals with ACHM, eight genes impli-
cated in COD, and 17 genes implicated in CRD (RetNet,
see Web Resources).1,7–9 Cone disorders can follow all
modes of Mendelian inheritance and manifest as nonsyn-
dromic and syndromic forms.1,2 Cone-disease-associated
genes encode proteins that fulfill crucial roles in the cone
phototransduction cascade, transport processes toward or
through the connecting cilium, cell membrane morpho-
genesis and maintenance, synaptic transduction, and the
retinoid cycle.1,7–9
Whole-exome sequencing (WES) has proven to be very
effective in the discovery of genetic defects in inherited
retinal diseases.10–14 Here, we report the identification by
WES of mutations in POC1B (MIM 614784), encoding a
protein previously associated with basal body stability,15
underlying autosomal-recessive COD or CRD. In addition,
we provide an integrated functional approach to substanti-
ate the causality of the identified mutations.Box 9101, 6500 HB Nijmegen, the Netherlands; 2Radboud Institute for
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Figure 1. POC1B Mutations in Families Affected by COD or CRD
(A) Sanger sequencing showed the segregation of the homozygous missense mutation M1 (c.317G>C [p.Arg106Pro]) in family A and
mutations M2 (c.199_201del [p.Gln67del]) and M3 (c.810þ1G>T) in family B.
(B) mRNA RT-PCR studies showed a normal 421 bp product and aberrant 387 and 271 bp products lacking exon 7 and exons 6 and 7,
respectively. The 387 and 271 bp cDNA deletions result in the predicted truncated POC1B products p.Val226Glyfs*30 (c.677_810del) and
p.Phe188Aspfs*73 (c.561_810del), respectively.
(C) Evolutionary conservation of amino acid residues Gln67 and Arg106 in POC1B. The glutamic acid at position 67 is moderately
conserved, whereas the arginine at position 106 is completely conserved among the listed species. Identical amino acids are indicated
in black boxes, and conserved residues are indicated in gray boxes.Material and Methods
Subjects and Clinical Evaluation
A nonconsanguineous Turkish family (family A) with three
siblings affected by COD and CRD and an isolated Dutch individ-
ual (family B) with ACHM that evolved into a progressive retinal
dystrophy were included in this study (Figure 1A). These families
belong to a large cohort of individuals affected by ACHM
(n ¼ 21), COD (n ¼ 110), or CRD (n ¼ 112). Most of the probands
are the only affected persons in their family, and they were ascer-
tained in various ophthalmic centers in the Netherlands, Belgium,
the United Kingdom, and Canada. The individuals diagnosed with
ACHM had a history of congenital pendular nystagmus, reduced
visual acuity, photophobia, and poor or absent color vision in
early infancy and had absent cone function (but normal rod
responses) on ERG. Individuals in our cohort were classified as
having COD when they presented with a childhood or early-
adult-onset progressive deterioration of visual acuity and color
vision, reduced cone responses on ERG, and normal rod responses
for R5 years.6 Inclusion criteria for CRD were progressive loss
of central vision, color-vision disturbances, and a reduction of
both cone (equally or more severely reduced) and rod responses
on ERG.6
After identification of the genetic defect, the medical records of
the affected individuals of families A and B were evaluated.
Ophthalmologic examinations were performed on several occa-
sions and included best-corrected visual acuity (Snellen chart),
slit-lamp biomicroscopy, ophthalmoscopy, color-vision testing
(Hardy-Rand-Rittler color-vision test and Lanthony panel D-15132 The American Journal of Human Genetics 95, 131–142, August 7tests), and visual-field testing using Goldmann kinetic perimetry
(targets V-4e and I-4e to I-1e). Fundus photographs of both the
macular area and the four peripheral quadrants were available
for two individuals. ERG was performed according to the protocol
of the International Society for Clinical Electrophysiology of
Vision.16 Time-domain optical coherence tomography (OCT; Stra-
tus OCT 3000, Carl Zeiss Meditec) was obtained in one affected in-
dividual (A-II:4), and spectral-domain OCT (SD-OCT; Heidelberg
Spectralis HRAþOCT, Heidelberg Engineering; 30 single-line
scans, ten frames per line) was obtained in proband B-II:1. The
acquisition of SD-OCT was limited as a result of nystagmus. This
study was approved by the institutional review boards of the
participating centers and adhered to the tenets of the Declaration
of Helsinki. All subjects provided written informed consent prior
to participation in the study.
Exome Sequencing and Variant Identification
A SOLiD4 sequencing platform (Life Technologies) was utilized for
WES in 12 CRD- or COD-affected probands from families with
suspected autosomal-recessive inheritance, and the exomes were
enriched according to the manufacturer’s protocol with the use
of the SureSelect Human All Exon v.2 Kit (50 Mb), containing
the exonic sequences of approximately 21,000 genes (Agilent
Technologies). LifeScope software v.2.1 (Life Technologies) was
used for mapping color space reads along the hg19 reference
genome assembly (UCSC Genome Browser). Single-nucleotide
variants were called by high-stringency calling with the DiBayes
algorithm. Small insertions and deletions were detected with the
SOLiD Small Indel Tool (Life Technologies). For individual A-II:1,, 2014
69,686,646 reads were uniquely mapped to the gene-coding re-
gions; median coverage was 58.23, and there were 44,784
sequence variants. For proband B-II:1, 75,493,298 reads were
uniquely mapped to the gene-coding regions; median coverage
was 66.73, and there were 47,304 sequence variants. For vali-
dating the WES sequence variants and excluding the presence of
other POC1Bmutations, all coding exons and exon-intron bound-
aries of POC1Bwere amplified with primers designedwith Primer 3
software (Table S1, available online).mRNA Analysis by RT-PCR
For assessing the effect of c.810þ1G>T on the POC1B transcript,
total RNA was isolated from peripheral-blood cells from the
affected person B-II:1 and three control individuals according to
the manufacturer’s (QIAGEN) protocol. The peripheral-blood cells
of B-II:1 and the control individuals were cultured according to
standard procedures with the use of phytohaemagglutinine. The
leukocytes of the affected individual were grown for 4–6 hr with
or without cycloheximide for visualization of the effect of the
mutation and possible degradation of nonsense-containing
mRNAs by nonsense-mediated decay.17 With the use of a hypo-
tone osmotic shock and centrifugation, the leucocytes were sepa-
rated from the erythrocytes. Reverse transcription with iScript
(Biorad) was performed on 1 mg of total RNA. RT-PCR experiments
were performed with 2.5 ml cDNA with primers in exons 5 and 9
(Table S2) (35 cycles) and were followed by Sanger sequencing
using a 3100 or 3730 DNA Analyzer (Applied Biosystems).Zebrafish Morpholino Knockdown
Tupfel long fin zebrafish were bred and raised under standard
conditions.18 All experiments were carried out in accordance
with European guidelines on animal experiments (2010/63/EU).
Zebrafish eggs were obtained from natural spawning. Antisense
morpholino oligonucleotides (MOs) blocking the translation
(50-GATCCTCCATTACAGACGCCATGAT-30) or the 50 splice site
of exon 2 (50-AAGTTCTCTGTCTTATTCAGGAGGA-30) of poc1b15
were obtained from GeneTools. A MO directed against a human
b-globin intronic mutation (50-CCTCTTACCTCAGTTACAATT
TATA-30) was used as a standard negative control. For MO knock-
down, 1 nl of diluted MO (ranging from 2 to 10 ng) was injected
into the yolk of 1- to 2-cell-stage embryos with a Pneumatic
PicoPump pv280 (World Precision Instruments). A minimum
sample size of 80 larvae was used in each injection experiment.
After injection, embryos were raised at 28.5C in E3 embryo
medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and
0.33 mM MgSO4) supplemented with 0.1% (w/v) methylene
blue. At 4 days postfertilization (dpf), embryos were divided
into two groups on the basis of the presence of the ocular pheno-
type described by Pearson et al.15 (<15 arbitrary units on a stereo-
microscope’s ocular scale bar; Zeiss). For both groups of embryos,
as well as injected and uninjected controls, optokinetic responses
(OKRs) were measured and histological analysis of the retina was
performed.
cDNAs encoding human wild-type and variant (p.Gln67del and
p.Arg106Pro) proteome of centriole 1B (POC1B, previously Pix1)
were cloned in pCS2þ/DEST with the use of Gateway Technology
(Life Technologies), linearized, and used as templates for in vitro
transcription. mRNAs were prepared with the mMESSAGE
mMACHINE Kit (Life Technologies) according to the manufac-
turer’s instructions. A dose of 100 pg mRNA was injected with
the MOs as described above.The AmerZebrafish OKR Assay
The OKR was measured by a previously described method.19
Zebrafish larvae were mounted in an upright position in 3%meth-
ylcellulose in a small Petri dish. The Petri dish was placed on a plat-
form surrounded by a rotating drum 8 cm in diameter. A pattern of
alternating black and white vertical stripes was displayed on the
drum interior (each stripe subtended an angle of 36). Larvae
(4 dpf) were visualized through a stereomicroscope positioned
over the drum and illuminated with fiberoptic lights. Eye move-
ments were recorded while larvae were optically stimulated by
the rotating stripes. Larvae were subjected to a protocol of a 30 s
counterclockwise rotation, a 10 s rest, and a 30 s clockwise rota-
tion. Thereafter, the larvae were washed out of themethylcellulose
and fixed for histological analysis.
Staining of Photoreceptor Outer Segments in
Zebrafish Embryos
Larvae (4 dpf) tested for OKR were fixed in 4% formaldehyde in
PBS for 24 hr, dehydrated through graded ethanol steps from
70% to 100%, and embedded via a standard protocol in glycol
methacrylate. The eyes were sectioned (2 mm), stained with
boron-dipyrromethene (1:10,000 in PBS) for membranes and
with DAPI (1:8,000) for nuclei, and imaged with a Zeiss Axio
Imager Z1 fluorescence microscope.
Immunostaining and Microscopy
Zebrafish and rat samples for immunohistochemistry (unfixed and
fixed in 4% paraformaldehyde) were rinsed in 30% sucrose in PBS
and directly frozen in Tissue Tek in melting isopentane. Cryosec-
tions of unfixed adult zebrafish and rat eyes (7 mm) were stained
for Poc1b with anti-hsPOC1B (1:50; generously provided by
Chad Pearson and Mary Pinter, University of Colorado) as
described for cultured cells by Pearson et al.15 Sections were coun-
terstained with GT335 (1:100; mouse monoclonal antibody
against polyglutamylated tubulin, kindly provided by Carsten
Janke, Centre National de la Recherche Scientifique Centre de
Recherches en Biochimie Macromoleculaire). Sections of fixed
zebrafish morphants were stained for green and red double cones
with a mouse monoclonal antibody (zpr-1, raised against Arr3a,
1:500; ZIRC) and for rods with anti-rhodopsin (1:500; Novus
Biologicals). Sections were washed with PBS, permeabilized for
20 min in 0.01% (v/v) Tween-20 in PBS, and washed again.
Next, sections were blocked with 10% normal goat serum and
2% BSA in PBS, and primary antibodies were incubated overnight
at 4C in blocking buffer. After washing with PBS, secondary anti-
bodies were incubated in blocking buffer for 45 min at room tem-
perature. Samples were counterstained with DAPI and mounted
with Prolong Gold (Life Technologies). For all sections, goat anti-
mouse or goat anti-rabbit (Alexa 488 or 568, respectively, 1:500;
Life Technologies) secondary antibody was used.
cDNA Constructs
All expression constructs were created with Gateway Technology
(Life Technologies) according to the manufacturer’s instructions.
These constructs encoded 33HA-POC1B wild-type and variants
(p.Arg106Pro and p.Gln67del) and 33FLAG-FAM161A for coim-
munoprecipitation and encoded monomeric red fluorescent
protein (mRFP)-POC1B wild-type and variants and PalmMyr-
CFP-FAM161A for colocalization studies. cDNA constructs encod-
ing the full-length POC1B of 478 amino acids (POC1B; RefSeq
accession numbers NM_172240.2 [gene] and NP_758440.1ican Journal of Human Genetics 95, 131–142, August 7, 2014 133
[protein]) or different fragments thereof were generated by
Gateway-adapted PCR and subsequently cloned.20 The first frag-
ment (POC1B-WD40) spanned amino acids 1–297 and contained
the WD40 domain. The second fragment (POC1B-SR) spanned
amino acids 298–426 and did not hold any known domains.
The third fragment (POC1B-CC) spanned amino acids 427–478
and contained a single coiled-coil domain (Figure S1). Constructs
encoding POC1B variants p.Gln67del and p.Arg106Pro were
generated by site-directed mutagenesis PCR. Constructs encoding
the full-length FAM161A were generated from a full-length
FAM161A clone.21 The sequence of all entry clones was verified
by Sanger sequencing.Yeast Two-Hybrid Assay
The GAL4-based yeast two-hybrid system (HybriZAP, Stratagene)
was used for identifying binary protein-protein interaction part-
ners of POC1B. The construct encoding the full-length POC1B
and the three constructs encoding fragments of POC1B were fused
to a DNA binding domain (GAL4-BD) and used as bait for
screening a human oligo-dT-primed retinal cDNA library. The
yeast strain PJ69-4A, which carries the HIS3 (histidine), ADE2
(adenine), and LacZ (b-galactosidase) reporter genes, was used as
a host. Interactions were analyzed by assessment of reporter
gene (HIS3 and ADE2) activation via growth on selective media
and b-galactosidase colorimetric filter lift assays (LacZ reporter
gene). cDNA inserts of clones containing putative interaction part-
ners were confirmed by Sanger sequencing.Localization in hTERT-RPE1 Cells
Human TERT-immortalized retinal pigment epithelium 1 (hTERT-
RPE1) cells were cultured as previously described.22 Cells were
seeded on coverslips, grown to 80% confluency, and subsequently
serum starved for 24 hr in medium containing only 0.2% fetal calf
serum for inducing cilium growth. The cells were then cotrans-
fected with constructs encoding mRFP-POC1B (wild-type or
variants) and PalmMyr-CFP-FAM161A (wild-type) with the use
of Lipofectamine 2000 (Life Technologies) according to the man-
ufacturer’s instructions. Cells were fixed in 4% paraformaldehyde
for 20 min, treated with 1% Triton X-100 in PBS for 5 min, and
blocked in 2% BSA in PBS for 20 min. Cells were incubated with
the primary antibody GT335 (cilium and basal body marker,
1:500) and a-RPGRIP1L (SNC039 þ SNC040,23 transition zone
marker, 1:500), diluted in 2% BSA in PBS, for 1 hr. After washing
in PBS, the cells were incubated with the secondary antibody for
45 min. Secondary antibodies goat anti-mouse, goat anti-guinea
pig, and goat anti-rabbit (Alexa 488, 568, and 647, respectively,
1:500; Life Technologies) were diluted in 2% BSA in PBS. Cells
were washed with PBS and briefly with milliQ before being
mounted in Vectashield containing DAPI (Vector Laboratories).
The cellular localization of wild-type and variant POC1B proteins
was analyzed with a Zeiss Axio Imager Z1 fluorescence microscope
equipped with a 633 objective lens. Optical sections were gener-
ated through structured illumination by the insertion of an
ApoTome slider into the illumination path and subsequent
processing with AxioVision (Zeiss) and Photoshop CS4 (Adobe
Systems) software.Coimmunoprecipitation
33HA-POC1B (wild-type and variants) and 33FLAG-FAM161A
were cosynthesized in human embryonic kidney 293T
(HEK293T) cells. As a negative control, the functionally unrelated134 The American Journal of Human Genetics 95, 131–142, August 7p63 was cosynthesized with both POC1B and FAM161A. As
positive controls, the previously described interactions between
nephrocystin-4 (encoded by NPHP4 [MIM 607215]) and
RPGRIP124 and between lebercilin (encoded by LCA5 [MIM
611408]) and FAM161A were used.21 After 48 hr of expression of
these genes, cells were lysed on ice in lysis buffer (50 mM Tris-
HCL [pH 7.5], 150 mM NaCl, and 0.5% Triton X-100) supple-
mented with complete protease inhibitor cocktail (Roche). Lysates
were incubated with anti-HA affinity matrix (Roche) or with anti-
FLAG M2 agarose from mouse (Sigma-Aldrich) for 5 hr at 4C.
After incubation, beads with bound protein complexes were
washed in lysis buffer and subsequently taken up in 43 NuPAGE
Sample Buffer and heated for 10 min at 70C. Beads were precipi-
tated by centrifugation, and supernatant was run on a NuPAGE
Novex 4%–12% Bis-Tris SDS-PAGE gel. The interaction between
33HA-POC1B and 33FLAG-FAM161A was assessed by immuno-
blotting, followed by staining with either monoclonal mouse
anti-HA or monoclonal mouse anti-FLAG (1:1,000; Sigma-Aldrich)
as a primary antibody and goat anti-mouse IRDye800 (1:20,000;
Li-Cor) as a secondary antibody. Fluorescence was analyzed on a
Li-Cor Odyssey 2.1 infrared scanner.Results
Identification of POC1B Mutations
To localize the genetic defect in a Turkish family with three
siblings affected by COD or CRD (family A; Figure 1A), we
performed exome sequencing in A-II:1. Putative causal
mutations were selected when present with a frequency
< 0.5% in dbSNP and our in-house controls (n ¼ 2,604
alleles) and when they represented nonsense, frameshift,
canonical splice-site, or missense mutations with a PhyloP
score > 2.7 (range 14.1–6.4).25 Under the assumption of
autosomal-recessive inheritance, we identified potential
compound-heterozygous mutations (present in >20%
sequence-variant reads) in ASTE1, CNTN3 (MIM 601325),
and TUBGCP2; Sanger sequencing of these mutations
showed that they did not segregate with the disease. We
identified one potential homozygous mutation (present
in >80% sequence-variant reads; Table S3), c.317C>G
(p.Arg106Pro) in POC1B (MIM 614784), and upon Sanger
sequence analysis, it was found to be present in a homozy-
gous state in the three affected siblings and in a heterozy-
gous state in the parents and unaffected sibling (Figure 1A).
The arginine at position 106 is highly conserved up to
Chlamydomonas (Figure 1C). The c.317 position has a
high PhyloP score of 6.1, and the c.317C>G mutation
was not identified in 189 ethnically matched controls or
in the NHLBI Exome Sequencing Project Exome Variant
Server (EVS, release ESP6500).
Using the same stringent sequence-variant filtering as
for family A, exome sequencing in the Dutch family B
(proband B-II:1, diagnosed with atypical ACHM;
Figure 1A) identified three genes with potential com-
pound-heterozygous mutations (Table S4). The sequence
variants in NUDT14 (MIM 609219) and PIKFYVE (MIM
609414) did not segregate with the disease. In POC1B, we
identified a 3 nt deletion, c.199_201del (p.Gln67del), and, 2014
Table 1. Summary of the Clinical Data of Four Individuals with POC1B Mutations
Family A Family B
Subject A-II:1 Subject A-II:3 Subject A-II:4 Subject B-II:1
Gender female female male male
Nystagmus present absent absent present
First documented
visual acuity (age)
RE: 0.16
LE: 0.16
(3 years)
RE: 0.8
LE: 0.8
(10 years)
RE: 1.0
LE: 0.8
(3 years)
RE: 0.2
LE: 0.2
(14 years)
Last documented
visual acuity (age)
RE: CF
LE: 0.1
(16 years)
RE: 0.3
LE: 0.2
(19 years)
RE: 0.16
LE: 0.2
(9 years)
RE: 0.05
LE: 0.05
(60 years)
Refraction,
D SE (age)
RE: 6 D
LE: 6 D
(16 years)
RE: 1 D
LE: 1 D
(19 years)
RE: þ0.5 D
LE: plano
(9 years)
RE: 2.50 D
LE: 2.25 Da
(59 years)
Funduscopy
(age)
subtle RPE disturbances
in the periphery;
otherwise normal
(9 years)
relative hypopigmentation
in the periphery;
otherwise normal
(12 years)
bone-spicule pigmentations
in the periphery;
otherwise normal
(6 years)
pallor optic disc, attenuated vessels,
no RPE disturbances at the macula,
RPE atrophy with bone-spicule
pigmentations in the periphery of
the inferior quadrants
(60 years)
OCT (age) NP NP intact inner-segment
ellipsoid zone, no foveal
hypoplasia (7 years)
changes at inner-segment ellipsoid
zone, no foveal hypoplasia (60 years)
Color vision
(age)
tritan defect
(9 years)
tritan defect in RE,
anomaloscope showed
red shift in both eyes
(11 years)
NP defects in all axes (55 years)
Goldmann
visual field
(age)
relative central scotoma,
mild peripheral
constriction
(13 years)
relative central scotoma,
mild peripheral
constriction
(11 years)
relative central scotoma,
mild peripheral constriction
(6 years)
central scotoma, peripheral
constriction (58 years)
ERG (age) nonrecordable cone
responses, normal
rod responses
(9 and 13 years)
severely reduced cone
responses, normal
rod responses
(11 years)
nonrecordable cone
responses, severely reduced
rod responses
(6 years)
nonrecordable cone responses,
normal rod responses (14 years);
nonrecordable cone responses,
significantly reduced rod responses
(55 years)
Final diagnosis COD COD CRD CRD
Visual acuity is in Snellen decimals. Abbreviations are as follows: CF, counting finger; COD, cone dystrophy; CRD, cone-rod dystrophy; D, diopter; ERG, electro-
retinography; LE, left eye; NP, not performed; OCT, optical coherence tomography; RE, right eye; RPE, retinal pigment epithelium; and SE, spherical equivalent.
aRefractive error before cataract extraction at 59 years of age.a mutation affecting a canonical splice-site nucleotide,
c.810þ1G>T. By RT-PCR of this individual’s lymphoblast
mRNA, the latter mutation was shown to induce skipping
of exons 6 and 7 (c.561_810del; minor mutant product) or
exon 7 (c.677_810del; major mutant product) (Figure 1B)
and thus result in the predicted truncated proteins
p.Phe188Aspfs*73 and p.Val226Glyfs*30, respectively.
Segregation analysis confirmed that both parents carry
one of these POC1B mutations (Figure 1A). Neither muta-
tion was identified in 149 ethnically matched controls or
the NHLBI EVS. The glutamine at position 67 ismoderately
conserved up to Xenopus (Figure 1C).
Genome-wide SNP homozygosity-mapping data of>400
unrelated individuals with autosomal-recessive CRD, Leber
congenital amaurosis, and retinitis pigmentosa (RP
[MIM 268000]) were assessed through the European
Retinal Disease Consortium10,26 and allowed the identifi-
cation of eight probands with a large homozygous regionThe Amerspanning POC1B. However, Sanger sequencing of POC1B
in these probands did not reveal additional pathogenic
mutations. Subsequent Sanger sequence analysis of
POC1B in a more specific cohort, i.e., in individuals diag-
nosed with ACHM (n ¼ 21), COD (n ¼ 110), or CRD
(n ¼ 112), also did not reveal additional individuals with
POC1B mutations.
Clinical Features of Affected Individuals of Families A
and B
Table 1 presents a summary of the clinical features of the
four individuals with POC1B mutations. Fundus and
OCT images are depicted in Figure 2. The proband
(A-II:1) of family A presented with reduced visual acuity
in early infancy and mild nystagmus. The diagnosis of
incomplete ACHM was contemplated on the basis of
ERG showing absent cone function but normal rod
responses at the age of 9 years. In the following years,ican Journal of Human Genetics 95, 131–142, August 7, 2014 135
Figure 2. Clinical Presentation of Sub-
jects with POC1B Mutations
(A and B) Fundus photography of the right
eye of individual A-II:3 of family A at 12
years of age. (A) Posterior pole with normal
macular region. (B) Peripheral field with
relative hypopigmentation (*), but no
pathologic RPE changes.
(C and D) Fundus photography of the
right eye of individual B-II:1 of family B
at 60 years of age. (C) Posterior pole with
optic nerve pallor (*), attenuated vessels
(arrowhead), and no RPE disturbances at
the macula. (D) Peripheral inferior field
with mild RPE atrophy and bone-spicule
pigmentations (arrowhead).
(E) OCT of the left eye of individual B-II:1
showed no foveal hypoplasia but did
show changes at the inner-segment ellip-
soid zone (arrow) and adherent posterior
hyaloid membrane (*).however, visual acuity seemed to deteriorate, and a few
years later, her two younger siblings experienced a rapid
loss of central vision, suggesting COD (Figures 2A and
2B) in two siblings and CRD in one sibling. No long-term
data are available on these three persons. In contrast,
B-II:1 was followed for more than 40 years. He was also
diagnosed with ACHM in childhood on the basis of the
classical signs of reduced visual acuity, photophobia,
nystagmus, very poor color vision, and matching ERG
responses. In his fifth decade, visual acuity began to drop
slowly, and in his sixth decade, degenerative changes con-
sisting of RPE atrophy and bone-spicule pigmentations
were noted in the periphery of the inferior quadrant (Fig-
ures 2C and 2D). On OCT, changes at the inner-segment
ellipsoid zone were observed, suggesting the loss of junc-
tions between inner and outer segments (Figure 2E). ERG
at 55 years of age showed absent cone and significantly
reduced rod responses. Altogether, the diagnosis changed
from isolated cone dysfunction to progressive cone-rod
disease. Systematically, he was treated for hypertension
and had normal renal function.
Localization of POC1B in Human hTERT-RPE1 Cells
To investigate the effect of the identified POC1Bmutations
on the subcellular localization of the encoded protein, we
synthesized wild-type and variant recombinant POC1B136 The American Journal of Human Genetics 95, 131–142, August 7, 2014proteins, fused to mRFP, in ciliated
hTERT-RPE1 cells. Wild-type POC1B
localization was concentrated at the
ciliary basal body, as indicated by
costaining with the anti-polygluta-
mylated tubulin antibody GT335,
although some diffuse cytoplasmic
localization was also observed
(Figure 3A; Figure S2A). This confirms
previous results of Venoux et al.20 In
contrast, variant POC1B proteins,carrying either the p.Gln67del (Figure 3B; Figure S2B) or
the p.Arg106Pro (Figure 3C; Figure S2C) amino acid
change, completely lost their ciliary localization.
Localization of Poc1b in Photoreceptor Cells
The retinal function of Poc1b was evaluated in zebrafish.
Staining with anti-human POC1B showed that the protein
was located at the basal bodies of both the inner and the
outer photoreceptor layers of the adult zebrafish retina
(Figure 4A). In a focal plane different from the basal bodies,
some staining was also observed at the outer limit of the
outer nuclear layer (data not shown). Poc1b immunostain-
ing was also detected at the basal body of rat photorecep-
tors cells (Figure S3).
Poc1b Knockdown Results in Visual Impairment in
Zebrafish
Poc1b morphants display the typical ciliopathy pheno-
types previously described by Pearson et al.,15 including
pericardial edema, small eyes, pigment mislocalization,
and a shortened and curved body axis (Figure S4A). Small
eyes were already observed in larvae treated with 2 ng
MO and became more frequent as the dose increased
(Figure 4B; Figure S4B). At a dose of 6 ng MO, smaller
eyes occurred in 39.8% of morphants and were on average
significantly smaller than wild-type eyes (Figure 4B;
Figure 3. Subcellular Localization of Wild-Type and Variant POC1B in hTERT-RPE1 Cells
Localizations of wild-type mRFP-POC1B (A), mRFP-POC1B-p.Gln67del (B), and mRFP-POC1B-p.Arg106Pro (C) (all in red). Additional
images are shown in Figure S2. Cilia were counterstained with the basal body and cilium marker GT335 (green) and transition-zone
marker RPGRIP1L (cyan). Wild-type mRFP-POC1B showed cytosolic localization with enrichment at the basal body region, as seen in
the magnifications in the insets. Both variants showed similar cytosolic localization but lacked enrichment at the base of the cilium.
In all pictures, nuclei were stained with DAPI (blue). Scale bars represent 10 mm.Figure S4B), and 92.5% of morphants displayed one or
more of the phenotypes described above without higher
mortality than in controls. Specificity of the MO knock-
down was previously verified with a second MO targeting
the 50 splice site of poc1b exon 2, which resulted in
59.1% of morphants with small eyes (Figure S4B).
The OKR was assessed in larvae injected with control
and poc1b MOs. OKR was absent or lower in morphants
with small eyes than in wild-type or control-MO-injected
larvae (Figure 4C; Movies S1 and S2). Morphants that
received the same dose of MO but had normal-sized eyes
responded normally to the OKR stimulus. This phenotype
was confirmed in larvae treated with a splice-site-blocking
MO (data not shown). Outer-segment length was not
affected in control-MO-injected larvae and morphants
that did show an OKR. Histological analysis of the retina
of the morphants subjected to OKR measurement revealed
shortened or absent outer segments of the photoreceptors,
whereas lamination appeared normal (Figures 4D and 4E).
We observed a perfect correlation between the small-eye
phenotype and a diminished or absent OKR. The size of
the eyes appeared to correlate with outer-segment lengthThe Amerand responsiveness to visual stimuli. As such, we could
quantify the size of the eye to measure the effects of loss
of Poc1b function. Indeed, coinjection of 100 pg human
wild-type POC1B mRNA, but not of c.199_201del
(p.Gln67del) or c.317C>G (p.Arg106Pro) mutant
POC1B mRNA, significantly rescued poc1b knockdown
(Figure 4B; Figure S4B).
Immunohistochemical staining for typical rod
(rhodopsin) and cone (zpr-1) markers was absent from a
subset of cells in morphants with smaller eyes
(Figure S4C). High-magnification pictures showed that
whereas immunostaining was absent in certain regions of
the morphant retina, the nuclei of the photoreceptor cells
were still present.
Identification of a Retinal Protein Interacting with
POC1B
To identify interaction partners of POC1B in the retina, we
employed a GAL4-based interaction trap screen in
yeast (yeast two-hybrid system). We screened a library ex-
pressing human retinal cDNAs for potential interactors of
POC1B. Both a construct expressing full-length POC1Bican Journal of Human Genetics 95, 131–142, August 7, 2014 137
Figure 4. Morphological and Functional Effects of MO Knockdown of poc1b in Zebrafish Larvae
(A) Localization of Poc1b (green) in the retina of adult zebrafish. The retina of adult zebrafish typically contains two layers of photore-
ceptor outer segments and associated basal bodies (OS layers 1 and 2). Both layers showed Poc1b immunoreactivity overlapping with and
adjacent to staining of GT335 (red), a marker of the connecting cilium. Abbreviations are as follows: OS, outer segment; CC, connecting
cilium; BB, basal body; IS, inner segment; and ONL, outer nuclear layer. The scale bar represents 15 mm.
(B) Phenotypic analysis of morphant eyes. Injection of 6 ng translation-blocking MO led to a higher number of small eyes than in
control-MO-injected larvae. The phenotype could be partially rescued by coinjection of wild-type POC1B mRNA, but not
c.199_201del (p.Gln67del) or c.317C>G (p.Arg106Pro) mutant POC1B mRNA.
(C) Analysis of the OKR (Movies S1 and S2). Larvae with decreased responses were already observed in a pool of larvae injected with 2 ng
MO (indicated with an accolade). At this dose, there were also morphants that did respond to the visual stimulus.
(D) Sections of eyes injected with control or poc1bMOs were stained for outer segments (red) and nuclei (blue). Eyes of morphants that
did not respond to the visual stimulus were smaller. The scale bar represents 50 mm.
(E) Outer segments were decreased in length or absent in nonresponsive morphants (OKR), whereas outer segments were normal in
length in responsive larvae (OKRþ). The scale bar represents 10 mm.and constructs expressing different POC1B fragments were
used as baits (Figure S1). The fragment containing the
carboxy-terminal coiled-coil domain of POC1B was found
to putatively interact with five different proteins,
including FAM161A (Figure S5A). The interaction with
this known retinal-disease-associated protein21,27,28
caught our attention and was confirmed by a coimmuno-
precipitation assay using both full-length proteins
(Figure 5A). In the same assay, we investigated the effect
of the identified missense and single-amino-acid deletion
variants in POC1B on the interaction. Indeed, a signifi-
cantly lower amount of altered POC1B than wild-type138 The American Journal of Human Genetics 95, 131–142, August 7protein coprecipitated with FAM161A, indicating a disrup-
ted physical interaction. The unrelated p63 did not copre-
cipitate with either POC1B or FAM161A, which confirmed
specificity of the interaction between POC1B and
FAM161A in the coimmunoprecipitation assay. The
interaction between wild-type POC1B and FAM161A,
and the decreased interaction between variant POC1B
proteins and FAM161A, was confirmed by reciprocal coim-
munoprecipitation (Figure S5B). Uncropped images of the
immunoblots are shown in Figure S6.
To validate the loss of interaction between FAM161A
and variant POC1B in mammalian cells, we cotransfected, 2014
Figure 5. Coimmunoprecipitation and
hTERT-RPE1 Localization Studies of
POC1B and FAM161A
(A) Coimmunoprecipitation assay in
HEK293T cells. Wild-type 33HA-POC1B
efficiently coprecipitated with 33FLAG-
FAM161A (lane 1), but coprecipitation
was reduced for variants 33HA-POC1B-
p.Gln67del and 33HA-POC1B-p.Arg106-
Pro (panel 4, lanes 2 and 3). Specificity
was confirmed by inclusion of the un-
related p63, which failed to coimmunopre-
cipitate with wild-type and variant
POC1B. As positive controls, coimmuno-
precipitation of lebercilin (encoded by
LCA5) by FAM161A and of RPGRIP1 by
nephrocystin-4 (encoded by NPHP4) was
used. Immunoblots of the input are shown
in panels 1 and 2, and immunoblots of the
FLAG immunoprecipitates are shown in
panels 3 and 4. Size markers are depicted
in kDa.
(B) Colocalization in hTERT-RPE1 cells.
PalmMyr-CFP-FAM161A (green) was
targeted to the cell membrane and micro-
tubules and translocated wild-type mRFP-
POC1B (red) from the cytosol toward the
cell membrane and microtubules.
(C and D) This translocation by PalmMyr-
CFP-FAM161A (green) was not observed
for mRFP-POC1B-p.Gln67del (C, red) or
mRFP-POC1B-p.Arg106Pro (D, red), which
both maintained their cytosolic localiza-
tion. RPGRIP1L (magenta) was used as a
transition-zone marker of the cilium.
Nuclei were stained with DAPI (blue). Scale
bars represent 10 mm. Additional images
are shown in Figure S7.hTERT-RPE1 cells with constructs encoding wild-type
and variant mRFP-POC1B together with PalmMyr-CFP-
FAM161A (Figures 5B–5D; Figures S7A–S7C). The PalmMyr
tag provides residues for palmitoylation and myristoyla-
tion, which both induce membrane association of the pro-
tein of interest.29 This can subsequently be visualized by
fluorescence microscopy of the expression of the fluores-
cent CFP tag. Coexpression of FAM161A and POC1B
showed complete colocalization of the encoded proteins
at the plasma membrane, basal body, and association
with the microtubule network. When either one of the
mutations was present in the POC1B construct, the coloc-
alization with FAM161A was lost completely. PalmMyr-
CFP-FAM161A then maintained its membrane, basal
body, and microtubule association, but the localization
of variant POC1B was cytosolic without enrichment atThe American Journal of Human Gspecific subcellular sites (Figures 5C
and 5D; Figures S7B and S7C).
Discussion
In this study, we identified three
POC1B mutations that cause auto-somal-recessive COD or CRD. In two siblings of one family,
loss of central vision was observed in childhood, consis-
tent with progressive cone disease; however, in another
sibling and in one isolated individual, poor visual acuity
and nystagmus were present from early infancy, suggesting
a form of ACHM. In the latter two individuals, visual acuity
also deteriorated over time, and in one of them, peripheral
retinal degeneration was observed in the sixth decade.
Although there is overlap in genes associated with either
ACHM or COD as a result of mutations in CNGA3 (MIM
600053) and CNGB3 (MIM 605080),5,30,31 there are, to
our knowledge, no reports on the natural history of
ACHM concerning peripheral degeneration.
POC1B is one of the two POC1 homologs that function
together as a highly conserved core centriole and basal
body component in vertebrates,15,32–34 invertebrates,35,36enetics 95, 131–142, August 7, 2014 139
and even Chlamydomonas reinhardtii32 and Tetrahymena
thermophila.33 The other POC1 homolog, encoded by
POC1A (previously Pix2 [MIM 614783]), shows protein
structure and intracellular localization similar to those of
POC1B.20,36 Studies in Tetrahymena thermophila suggest
that POC1 proteins are essential for both structure and sta-
bility of the basal body.15 Depletion studies show that
POC1B, unlike POC1A, is necessary for ciliogenesis, and
typical ciliopathy-associated developmental defects (e.g.,
curved body axis, kidney cysts, and laterality defects)
were described in poc1bmorphant zebrafish. Interestingly,
they were also reported to exhibit smaller eyes, but a more
detailed ophthalmological analysis was not undertaken.15
In light of the retinal phenotype we observed in affected
individuals with POC1B mutations and the reported
smaller eyes in poc1b morphant zebrafish, we disrupted
poc1b expression by using the same translation-blocking
MO used by Pearson et al.15 An accurate evaluation of
Poc1b function in the eyes indeed confirmed that the pro-
tein is required for normal vision, given that the Poc1b-
depleted zebrafish showed a severely decreased OKR in
combination with smaller eyes (Figure 4C). Analysis of
morphant eyes revealed decreased length of photoreceptor
outer segments in the cone-dominated larval retina (Fig-
ures 4D and 4E). Poc1b appeared to be present at all basal
bodies of vertebrate photoreceptors, suggesting that loss
of function affects both rods and cones (Figure 4A;
Figure S3). Indeed, knockdown of poc1b reduced immuno-
reactivity for important proteins in the light-transduction
cascade of rod and cones alike (Figure S4C). This corre-
sponds with the decreased visual response of poc1b mor-
phants, measured in the OKR assay. Rescue of the smaller
eyes associated with this phenotype was achieved with
wild-type human POC1B mRNA.
The affected amino acids identified in this study are
moderately or highly conserved in evolution (Figure 1C),
and both affect the N-terminal WD40 domain
(Figure S1). The third mutation alters the splice site of
exon 7 and results in a truncation of the protein within
the last WD40 repeat. This WD40 domain, but not the
C-terminal region of POC1, has been demonstrated to be
sufficient for targeting POC1 localization to centrioles.32
Indeed, whereas wild-type POC1B localized to the basal
bodies, as previously reported, both p.Gln67del and
p.Arg106Pro variant POC1B revealed a loss of association
with the basal body of the cilium (Figure 3). The effect of
the variants on Poc1b in zebrafish was addressed by coin-
jection of a poc1b MO in combination with human
POC1B mRNA carrying either one of the mutations. In
contrast with coinjection of wild-type mRNA, coinjection
of the mutated mRNA could not induce (partial) rescue
of the ocular phenotype, confirming the disturbing retinal
effect of the variant amino acid residues (Figure 4B).
To provide further insights into the retinal function of
POC1B, we aimed to identify retinal proteins interacting
with POC1B by using a GAL4-based interaction trap screen
in yeast of a retinal cDNA library. Out of the four different140 The American Journal of Human Genetics 95, 131–142, August 7bait fragments of POC1B employed, only the coiled-coil
region was found to yield one significant interactor:
FAM161A. Interestingly, mutations in FAM161A lead
to another retinal ciliopathy, autosomal-recessive RP
(RP28).27,28 Binding of FAM161A was validated with coim-
munoprecipitation and colocalization studies (Figure 5).
Although the interaction was initially detected with a frag-
ment containing the coiled-coil region of POC1B, intro-
duction of the two POC1B variants in the WD40 domain
of the full-length protein strongly decreased its interaction
with FAM161A, reiterating the structural importance
of this domain. Because FAM161A was found to be a
retinal-ciliopathy-associated protein,21,37 the decreased
interaction we observed with this retina-specific protein
might induce degeneration of rod photoreceptors as a
result of POC1B mutations in individuals with CRD.
Pearson et al. showed that in the absence of Poc1b,
zebrafish present with various phenotypes that point
toward a syndromic ciliopathy.15 In contrast, the POC1B
mutations identified in this study are associated with a
much milder, nonsyndromic cone-disease phenotype in
two families. Although species-specific differences might
contribute to the observed phenotypic heterogeneity, on
the basis of the type and combinations of mutations iden-
tified and the reduced, but not absent, interaction between
the altered POC1B and the retina-specific FAM161A, it is
plausible to conclude that individuals with COD have re-
sidual POC1B activity. Combinations of more severe and/
or loss-of-function POC1B mutations therefore might be
associated with syndromic forms of retinal ciliopathies,
in line with the wide disease spectrum previously observed
for another ciliopathy-associated gene, CEP290 (MIM
160142).38–41
In conclusion, WES led to the identification of POC1B
mutations in two unrelated families affected by auto-
somal-recessive nonsyndromic COD or CRD. These
variants were found to disrupt the ciliary basal body
localization of POC1B and its interaction with a retina-
specific, RP-associated protein, FAM161A. Given that
loss of Poc1b in zebrafish furthermore resulted in early-
onset retinal dysfunction, this study highlights a basal
body protein photoreceptor module that contains
POC1B and FAM161A and is required for photoreceptor
homeostasis.Supplemental Data
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